Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene

Biomedical and Environmental Sciences

Volumn 19, Issue 1, 2006, Pages 35-41

  Cao, Feng ^a   Jin, Tai Yi ^a   Zhou, Yuan Fen ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Daidzein; ER ; ER ; Genistein; Isoflavones; LNCaP; PC 3; PTEN; VEGF

Indexed keywords

ANDROGEN RECEPTOR; ANTINEOPLASTIC AGENT; DAIDZEIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; ISOFLAVONE DERIVATIVE; LACTATE DEHYDROGENASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; VASCULOTROPIN A;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; COMPARATIVE STUDY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; PROSTATE TUMOR; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENE EXPRESSION REGULATION; GENISTEIN; HUMANS; ISOFLAVONES; L-LACTATE DEHYDROGENASE; MALE; PROSTATIC NEOPLASMS; PTEN PHOSPHOHYDROLASE; RECEPTORS, ANDROGEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33645983347     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Parkin D M (2001). Global cancer statistics in the year 2000. Lancet Oncology 2, 533-543.
2. Adlercreutz H (1995). Phytoestrogens: epidemiology and a possible role in cancer protection. Env Health Persp 103 (Suppl 7), 103-112.
3. Griffiths K, Morton M S, Denis L (1999). Certain aspects of molecular endocrinology that relate to the influence of dietary factors on the pathogenesis of prostate cancer. Eur Urol 35, 443-455.
4. Adlercreutz H, Mazur W, Bartels P (2000). Phytoestrogens and Prostate Disease. Journal of Nutrition 130, 658S-659S.
5. Santell R C, Chang Y C, Nair M G, et al. (1997). Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J Nutr 127, 263-269.
6. Laura S, Ramon P (2001). PTEN: Life as a Tumor Suppressor Experimental. Cell Resesrch 264, 29-41.
7. Kuiper G G, Enmark E, Pelto-Huikko M, et al. (1996). Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93, 5925-5930.
8. Migliaccio A, Castoria G, Di Domenico M, et al. (2002). Sex steroid hormones act as growth factors. The Journal of Steroid Biochemistry and Molecular Biology 83, 31-35.
9. Koul D, Shen R, Garyali A, et al. (2002). MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. Int J Oncol 21, 469-475.
10. Kumta S M, Huang L, Cheng Y Y, et al. (2003). Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions. Life Sciences 73, 1427-1436.
11. Culig Z (2003). Role of the androgen receptor axis in prostate cancer. Urology 62 (Suppl 1), 21-26.
12. Isaacs J, Coffey D (1981). Adaptation versus selection as the nanism responsible for the relapse of prostatic cancer to androgen ablation as stuieed in the Duning R-3327 H andnocarcinoma. Cancer Res 41, 5070-5079.
13. Kumi-Diaka J (2002). Chemosensitivity of human prostate cancer cells PC3 and LNCaP to genistein isoflavone and β-lapachone. Biology of the Cell 94, 37-44.
14. Crissman H A, Steinkamp J A (1982). Rapid, one step staining procedures for analysis of cellular DNA and protein by single and dual laser flow cytometry. Cytometry 3, 84-90.
15. Grunwald V, DeGraffenried L, Russel D, et al. (2002). Inhibitors of mTOR Reverse Doxorubicin Resistance Conferred by PTEN Status in Prostate Cancer Cells. Cancer research 62, 6141-6145.
16. Chen G D, Oliver R H, Leung B S, et al. (1999). Estrogen receptor α and β expression in the vaginal walls and uterosacral ligaments of premenopausal and postmenopausal women. Reproductive Biology 71, 1099-1102.
17. Zheng M H, Xu J, Robbins P, et al. (2000). Gene expression of vascular endothelial growth factor in giant cell tumors of bone. Hum Pathol 31, 804-812.
18. Kazuko S (2000). Synergistic effects of thearubigin and genistein on human prostate tumor cell (PC-3) growth via cell cycle arrest. Cancer Letters 151, 103-109.
19. Takashi K, Teruhiro N, Takejiro K (2002). Effect of flavonoids on cell cycle progression in prostate cancer cells. Cancer Letters 176, 17-23.
20. Kazuhiro S, Hidekazu K, Hiroshi M (2002). Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3. Int J Cancer 99, 846-852.
21. Huang H, Cheville J C, Pan Y, et al. (2001). PTEN Induces chemosensitivity in PTEN-mutated Prostate Cancer Cells by Suppression of Bcl-2 Expression. J Biol Chem 276, 38830-38839.
22. Whang Y E, Wu X, Suzuki H, et al. (1998). Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci USA 95, 5246-5250.
23. Cotroneo M S, Wang J, Eltoum I A, et al. (2001). Sex steroid receptor regulation by genistein in the prepubertal rat uterus. Mol Cell Endocrinol 173, 135-145.
24. Lamartiniere C A, Cotroneo M S, Fritz W A, et al. (2002). Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr 132, 552S-558S.
25. Denis L, Morton M S, Griffiths K (1999). Diet and its preventive role in prostatic disease. Eur Urol 35, 377-387.
26. Prins G S, Birch L (1997). Neonatal estrogen exposure up-regulates estrogen receptor expression in the developing and adult rat prostate lobes. Endocrinology 138, 1801-1809.
27. Sato T, Chiba A, Hayashi S, et al. (1994). Induction of estrogen receptor and cell division in genital tracts of male mice by neonatal exposure to diethylstilbestrol. Reprod Toxicol 8, 145-153.
28. Klein K O (1998). Isoflavones, soy-based infant formulas, and relevance to endocrine function. Nutr Rev 56, 193-204.
29. Strauss L, Makela S, Joshi S, et al. (1998). Genistein exerts estrogen-like effects in male mouse reproductive tract. Mol Cell Endocrinol 144, 83-93.
30. Li P, Yu X, Ge K, et al. (2002). Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer. Am J Pathol 161, 1467-74.
31. Sharma M, Chuang W W, Sun Z (2002). Phosphatidylinositol 3-Kinase/Akt Stimulates Androgen Pathway through GSK3β Inhibition and Nuclear β-Catenin Accumulation. J Biol Chem 277, 30935-30941.
32. Bektic J, Berger A P, Pfeil K, et al. (2004). Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor beta. Eur Urol 45, 245-251.